Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof

Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof

US Patent 11633430 · Granted Apr 25, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific chimeric antigen receptors targeting CD20 and BCMA2025
Combined chimeric antigen receptor targeting CD19 and CD20 and application there2025
Method for guaranteeing reliability of real-time scrambling and message transmis2025
T cell receptors recognizing MHC class II-restricted MAGE-A32025
Charging control method and charging control apparatus2025
Ophthalmic devices for light therapy2025
Extraction-free pathogen testing methods2025
Reagent and method for fluorescence quantitative real-time PCR detection of RCL2025
Reagent and method for fluorescence quantitative real-time PCR detection of RCL2025
Reagent and method for fluorescence quantitative real-time PCR detection of RCL2025
Bispecific chimeric antigen receptors targeting CD20 and BCMA2025
Bispecific chimeric antigen receptors targeting CD20 and BCMA2025